Literature DB >> 32145496

Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the population assessment of tobacco and health (PATH) study.

Tara Elton-Marshall1, Pete Driezen2, Geoffrey T Fong3, K Michael Cummings4, Alexander Persoskie5, Olivia Wackowski6, Kelvin Choi7, Annette Kaufman8, David Strong9, Shannon Gravely2, Kristie Taylor10, Jonathan Kwan5, Maansi Bansal-Travers11, Mark Travers11, Andrew Hyland11.   

Abstract

OBJECTIVES: To examine: (1) How perceptions of harm for seven non-cigarette tobacco products predict subsequent use; (2) How change in use is associated with changes in perceptions of product harm; (3) Whether sociodemographic variables moderate the association between perceptions and use.
METHODS: Data are from the adult sample (18+) of the Population Assessment of Tobacco and Health (PATH) Study, a nationally representative longitudinal cohort survey conducted September 2013-December 2014 (Wave 1 (W1) n = 32,320) and October 2014-October 2015 (Wave 2 (W2) n = 28,362).
RESULTS: Wave 1 users and non-users of e-cigarettes, filtered cigars, cigarillos, and pipes, who perceived these products as less harmful had greater odds of using the product at W2. For the other products, there was an interaction between W1 perceived harm and W1 use status in predicting W2 product use. At W2, a smaller percentage of U.S. adults rated e-cigarettes as less harmful than cigarettes compared to W1 (41.2% W1, 29.0% W2). Believing non-cigarette products to be less harmful than cigarettes was more strongly associated with subsequent product use in the oldest age group (55+ years) while weaker effects were observed in the youngest age group (18-24 years). This moderating effect of age was significant for e-cigarettes, hookah, traditional cigars, and cigarillos.
CONCLUSIONS: Strategies to prevent initiation and promote cessation of these products may benefit from understanding and addressing perceptions of these products.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  E-cigarettes; Harm perceptions; Tobacco products

Mesh:

Year:  2020        PMID: 32145496      PMCID: PMC7441471          DOI: 10.1016/j.addbeh.2020.106337

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  27 in total

1.  U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013-14 baseline wave 1 of the path study.

Authors:  Geoffrey T Fong; Tara Elton-Marshall; Pete Driezen; Annette R Kaufman; K Michael Cummings; Kelvin Choi; Jonathan Kwan; Amber Koblitz; Andrew Hyland; Maansi Bansal-Travers; Charles Carusi; Mary E Thompson
Journal:  Addict Behav       Date:  2018-11-17       Impact factor: 3.913

2.  Smokers' beliefs about the relative safety of other tobacco products: findings from the ITC collaboration.

Authors:  Richard J O'Connor; Ann McNeill; Ron Borland; David Hammond; Bill King; Christian Boudreau; K Michael Cummings
Journal:  Nicotine Tob Res       Date:  2007-10       Impact factor: 4.244

3.  A content analysis of smokeless tobacco coverage in U.S. newspapers and news wires.

Authors:  Olivia A Wackowski; M Jane Lewis; Cristine D Delnevo; Pamela M Ling
Journal:  Nicotine Tob Res       Date:  2013-01-03       Impact factor: 4.244

4.  Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011.

Authors:  Brian A King; Suhana Alam; Gabbi Promoff; Rene Arrazola; Shanta R Dube
Journal:  Nicotine Tob Res       Date:  2013-02-28       Impact factor: 4.244

5.  Patterns of cognitive dissonance-reducing beliefs among smokers: a longitudinal analysis from the International Tobacco Control (ITC) Four Country Survey.

Authors:  Omid Fotuhi; Geoffrey T Fong; Mark P Zanna; Ron Borland; Hua-Hie Yong; K Michael Cummings
Journal:  Tob Control       Date:  2012-01-03       Impact factor: 7.552

6.  Pseudoreplication: further evaluation and applications of the balanced half-sample technique.

Authors:  P J McCarthy
Journal:  Vital Health Stat 2       Date:  1969-01

7.  E-cigarette awareness and perceived harmfulness: prevalence and associations with smoking-cessation outcomes.

Authors:  Andy S L Tan; Cabral A Bigman
Journal:  Am J Prev Med       Date:  2014-04-30       Impact factor: 5.043

8.  Comparison of Direct and Indirect Measures of E-cigarette Risk Perceptions.

Authors:  Olivia A Wackowski; Michelle T Bover Manderski; Cristine D Delnevo
Journal:  Tob Regul Sci       Date:  2016-01-01

9.  Deficiencies in public understanding about tobacco harm reduction: results from a United States national survey.

Authors:  Marc T Kiviniemi; Lynn T Kozlowski
Journal:  Harm Reduct J       Date:  2015-07-02

10.  Notes from the field: electronic cigarette use among middle and high school students - United States, 2011-2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-09-06       Impact factor: 17.586

View more
  15 in total

1.  Prospective associations between nicotine beliefs and tobacco-related susceptibility, curiosity, and use in U.S. adults.

Authors:  Andrea C Villanti; Shelly Naud; Julia C West; Jennifer L Pearson; Olivia A Wackowski; Elizabeth Hair; Raymond S Niaura; Jessica M Rath
Journal:  Prev Med       Date:  2020-10-15       Impact factor: 4.018

2.  'It's like if a vape pen and a cigarette had a baby': a mixed methods study of perceptions and use of IQOS among US young adults.

Authors:  Zongshuan Duan; Daisy Le; Annie C Ciceron; Ruth Dickey-Chasins; Christina N Wysota; Yael Bar-Zeev; Hagai Levine; Lorien C Abroms; Katelyn F Romm; Carla J Berg
Journal:  Health Educ Res       Date:  2022-09-23

3.  Differences in cigarette smoking quit attempts and cessation between adults who did and did not take up nicotine vaping: Findings from the ITC four country smoking and vaping surveys.

Authors:  Shannon Gravely; Gang Meng; David Hammond; Andrew Hyland; K Michael Cummings; Ron Borland; Karin A Kasza; Hua-Hie Yong; Mary E Thompson; Anne C K Quah; Janine Ouimet; Nadia Martin; Richard J O'Connor; Katherine A East; Ann McNeill; Christian Boudreau; David T Levy; David T Sweanor; Geoffrey T Fong
Journal:  Addict Behav       Date:  2022-04-28       Impact factor: 4.591

Review 4.  Multiple Tobacco Product Use Conceptual Framework: A 2021 Update on Evidence.

Authors:  Dana Rubenstein; Lauren R Pacek; F Joseph McClernon
Journal:  Nicotine Tob Res       Date:  2022-07-13       Impact factor: 5.825

5.  Associations Between Nicotine Knowledge and Smoking Cessation Behaviors Among US Adults Who Smoke.

Authors:  L M Snell; S M Colby; T DeAtley; R Cassidy; J W Tidey
Journal:  Nicotine Tob Res       Date:  2022-04-28       Impact factor: 5.825

Review 6.  Tobacco harm reduction: Past history, current controversies and a proposed approach for the future.

Authors:  Dorothy K Hatsukami; Dana M Carroll
Journal:  Prev Med       Date:  2020-04-23       Impact factor: 4.018

7.  Experts' Perceptions of and Suggestions for Cigar Warning Label Messages and Pictorials.

Authors:  Olivia A Wackowski; Michelle Jeong; Kevin R J Schroth; Mariam Rashid; Cristine D Delnevo
Journal:  Nicotine Tob Res       Date:  2021-08-04       Impact factor: 4.244

8.  Identifying message content to reduce vaping: Results from online message testing trials in young adult tobacco users.

Authors:  Andrea C Villanti; S Elisha LePine; Julia C West; Tess Boley Cruz; Elise M Stevens; Haley J Tetreault; Jennifer B Unger; Olivia A Wackowski; Darren Mays
Journal:  Addict Behav       Date:  2020-12-11       Impact factor: 3.913

9.  Effect of brief nicotine corrective messaging on nicotine beliefs in persons who use opioids.

Authors:  Maria A Parker; Jodi E Byers; Andrea C Villanti
Journal:  Exp Clin Psychopharmacol       Date:  2021-07-22       Impact factor: 3.157

10.  Developing and Validating Measures of Absolute and Relative E-Cigarette Product Risk Perceptions: Single Items Can Be Surprisingly Comprehensive.

Authors:  Erin Keely O'Brien; Sabeeh A Baig; Alexander Persoskie
Journal:  Nicotine Tob Res       Date:  2022-02-14       Impact factor: 5.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.